Evidence map›Paper›PMID 42283392›Full record

ArticleProtein science : a publication of the Protein Society2026

Structure-activity relationship study shows versatility in substrate specificity for heterodisulfide reductase in methanogenic archaea.

Mahdi Faal Maleki, Joakim Bøgelund Jakobsen, Eva Danielle Schuiten, Tristan Wagner, André Luis Alves Neves, Lennart Bunch

Erratum issuedAbstract read
In one paragraph

Article in Protein science : a publication of the Protein Society, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

6 authors.

Mahdi Faal MalekiDepartment of Veterinary and Animal Sciences, Faculty of Health and Medical Sciences, University of Copenhagen, Frederiksberg, Denmark.ORCID 0000-0002-5283-9196
Joakim Bøgelund JakobsenDepartment of Drug Design and Pharmacology, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark.ORCID 0000-0003-4369-3858
Eva Danielle SchuitenMax Planck Institute for Marine Microbiology, Bremen, Germany.
Tristan WagnerMax Planck Institute for Marine Microbiology, Bremen, Germany.
André Luis Alves NevesDepartment of Veterinary and Animal Sciences, Faculty of Health and Medical Sciences, University of Copenhagen, Frederiksberg, Denmark.
Lennart BunchDepartment of Drug Design and Pharmacology, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark.

Funding

Novo Nordisk Foundation NNF21OC0070790
6 · The paper itself

Abstract

Hydrogenotrophic methanogens are anaerobic archaea that convert carbon dioxide and hydrogen into methane. Central to this process is the heterodisulfide reductase (Hdr), which catalyzes the reduction of the heterodisulfide made of coenzyme M and coenzyme B. In vivo, Hdr functions in association with electron-donating modules such as the [NiFe]-hydrogenase (HdrMvh), which supplies reducing equivalents derived from hydrogen oxidation. Here, we isolate the catalytic properties of Hdr by evaluating substrate turnover independently of its native electron-donating modules using an artificial electron donor system. The molecular features governing substrate recognition and turnover by Hdr were investigated through the design and synthesis of 18 non-endogenous analogs of the native heterodisulfide substrate (compounds 2a-r). We show that several non-endogenous disulfides can serve as alternative substrates for Hdr, including analogs with variation in the coenzyme B-derived amino acid moiety (O-phosphono-Ser, L-Asp, L-Glu, and 2-aminoadipic acid), and that the coenzyme M sulfonate can be replaced by a carboxylate group. In contrast, modifications that disrupt charge balance, chain length, or stereochemical compatibility result in loss of substrate activity and, in some cases, lead to inhibitory behavior, underscoring the narrow constraints required for productive catalysis.

Indexed as

Archaeal ProteinsOxidoreductasesStructure-Activity RelationshipSubstrate SpecificityArchaeal Proteinsheterodisulfide reductaseOxidoreductasescoenzyme M/coenzyme B analogselectron bifurcationenzyme kineticsheterodisulfide reductasemethane mitigationstructure–activity relationshipsubstrate specificity

Identifiers

PMID42283392
PMCPMC13261682

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.